蘇大維格(300331.SZ)一季度預盈900萬-1300萬元
格隆匯 4 月 9日丨蘇大維格(300331.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤900萬元-1300萬元,同比增長89.19%-173.27%。業績變動原因如下:
1、報吿期內,公司導光材料業務保持快速增長,微納新材料製造項目逐漸放量,帶動公司營業收入和淨利潤同比增長;
2、對外投資項目從建設到產出效益需要一定的時間。報吿期內,公司及子公司部分項目處於產能釋放階段,部分項目處於建設期,公司規模持續擴大,期間費用上升。
以上原因導致公司2021年第一季度歸屬於上市公司股東的淨利潤較上年同期實現增長。
報吿期內,非經常性損益對公司淨利潤的影響金額預計為200萬元-400萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.